Pierre-Joseph Pelletier
1788-1842 · Francés · Farmacología
Químico francés cuyo aislamiento de alcaloides vegetales (quinina, estricnina, cafeína, brucina) fue pionero en la metodología de extracción de compuestos puros que más tarde sería aplicada por Haycraft y Jacoby para obtener hirudina de las glándulas salivales de la sanguijuela medicinal.
Perfil
- Años de vida
- 1788-1842
- Nacionalidad
- French
- Época
- Siglo XIX
- Campo principal
- Farmacología
Afiliaciones institucionales
- École de pharmacie de Paris (Professor and later Director)
- Académie des sciences, Paris (member, 1840)
- Pelletier-Caventou quinine manufactory, Paris
Contribuciones clave
- Co-isolated quinine from Cinchona bark with Joseph Bienaimé Caventou in 1820 — a milestone in the chemistry of natural products and the foundation of modern antimalarial therapy.
- Co-isolated strychnine (1818), brucine and veratrine (1819), and caffeine (1821), establishing the conceptual category of the alkaloid as a class of nitrogen-containing plant secondary metabolites with potent physiological action.
- Developed the methodological template — solvent extraction, salt formation, recrystallization — that became the standard approach to isolating active principles from biological tissues throughout the nineteenth century.
- Co-founded the first industrial-scale quinine manufactory in Paris, demonstrating that pure-compound natural-product chemistry could supply therapy at clinical scale.
- Served as professor of natural history of medicines at the École de pharmacie de Paris and exercised wide influence on the next generation of French chemists.
Importancia para la hirudoterapia
Pierre-Joseph Pelletier never worked on leeches and never published on hirudin — yet his methodological contributions are foundational to the entire molecular era of hirudotherapy. The extraction work by which John Berry Haycraft discovered the anticoagulant action of leech extract in 1884, and by which Karl Jacoby named hirudin and patented its preparation in 1904, descends directly from the natural-product chemistry that Pelletier and his collaborator Joseph Caventou pioneered in Paris between roughly 1817 and 1825. Without this methodological tradition, the leech salivary gland would have remained a black box of unspecified bioactive secretions. The specific intellectual leap that Pelletier embodied was the move from describing the actions of a crude botanical or biological preparation (cinchona bark, opium, leech saliva) to isolating the single chemical principle responsible for those actions. Before Pelletier, pharmacology was largely the study of mixtures; after Pelletier, it became the study of pure compounds with definable molecular structure. This conceptual reorientation is precisely what made hirudin meaningful as a research subject: Haycraft did not merely show that leech saliva inhibited clotting (a fact known anecdotally for centuries), he isolated a discrete protein that did so reproducibly and which could in principle be characterized further. The American Society of Hirudotherapy includes Pelletier in its biographical registry as the patron of the natural-product chemistry tradition from which modern hirudin and leech-derived drug discovery descend. Every recombinant hirudin product on the market today, every Factor Xa inhibitor descended from antistasin or ghilanten, every destabilase research program, traces its methodological lineage through Markwardt's 1957 purification, through Jacoby's 1904 extraction, through Haycraft's 1884 discovery, back to Pelletier and Caventou's quinine in 1820. He is the indirect intellectual ancestor of the entire leech-pharmacology field.
Publicaciones clave
- Recherches chimiques sur les quinquinas (with J. B. Caventou) · Annales de chimie et de physique (1820)
- Sur un nouvel alcali végétal (la strychnine) trouvé dans la fève de Saint-Ignace, la noix vomique, etc. · Annales de chimie et de physique (1819)
- Note sur la caféine · Journal de pharmacie (1821)
Recursos externos
Investigación influenciada
Compuestos y áreas de investigación que se remontan a las contribuciones de esta figura:
Figuras relacionadas
John Berry Haycraft
1857-1922 · Británico (escocés)
Fisiólogo de Edimburgo que descubrió la hirudina en 1884, fundando la farmacología molecular moderna de la saliva de sanguijuela.
Carl Jacobj (Karl Jacoby)
1857-1944 · Alemán
Göttingen pharmacologist who gave the anticoagulant principle of leech extract its name, 'hirudin', patented its preparation, after which hirudin was sold commercially.
Fritz Markwardt
1924-2011 · Alemán (alemán oriental / RDA)
East German pharmacologist who isolated and characterised hirudin from the medicinal leech in the 1950s and later chronicled its path from leech extract to recombinant antithrombotic drugs.
John W. Fenton II
Estadounidense
American thrombin biochemist whose 1986 account of thrombin's active-site regions explained how hirudin blocks both the enzymatic and the receptor-mediated activities of the enzyme.